Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotterdam observational study of IVIg pharmacokinetics in CIDP
NL-OMON37960Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of immune globulin in chronic inflammatory demyelinating polyneuropathy (CIDP), sponsored by Erasmus MC. Primary endpoint: Serum IgG levels over two subsequent IVIg courses. Started Apr 2014; status: active, not recruiting.
02
Drugs
immune globulin
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on NL-OMON37960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37960.